Non-combustible polyesterpolyol and/or polyetherpolyol preblend for producing foamed products

Details for Australian Patent Application No. 2002302536 (hide)

Owner Solvay Fluor Und Derivate Gmbh

Inventors Recke, Dierk-Ingolf; Borner, Karsten; Zipfel, Lothar

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002302536

PCT Number PCT/EP02/04185

PCT Pub. Number WO2002/092676

Priority 101 23 604.2 16.05.01 DE

Filing date 16 April 2002

Wipo publication date 25 November 2002

Acceptance publication date 6 March 2008

International Classifications

C08G 18/00 (2006.01) Polymeric products of isocyanates or isothiocyanates

C08J 9/00 (2006.01) Working-up of macromolecular substances to porous or cellular articles or materials

C08J 9/14 (2006.01) Working-up of macromolecular substances to porous or cellular articles or materials

C08G 101/00 (2006.01)

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 101 23 604.2 16.05.01 DE

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002302536

6 March 2008 Application Accepted

  Published as AU-B-2002302536

29 May 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Solvay Fluor Und Derivate Gmbh, Application No. 2002302536, under INID (71), correct the name of the applicant to Solvay Fluor und Derivate GmbH

3 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002302537-PROCESS FOR THE CONDENSATION OF COMPOUNDS HAVING SILICON BONDED HYDROXY OR ALKOXY GROUPS

2002302535-HUMAN CELLULAR PROTEIN GASTROINTESTINAL GLUTATHIONE PEROXIDASE AS TARGET FOR MEDICAL INTERVENTION AGAINST HEPATITIS C VIRUS INFECTIONS